Schilder, Russel J.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Long-term responses in patients with recurring or refractory B-cell non-Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetan

Thomas E. Witzig, Arturo Molina, Leo I. Gordon, Christos Emmanouilides, Russell J. Schilder, Ian W. Flinn, Mohamed Darif, Roger Macklis, Katie Vo, Gregory A. Wiseman

Journal:

Year:

2007

Language:

english

File:

PDF, 205 KB

english, 2007

2

“Being dealt with as a whole person.” Care seeking and adherence: the benefits of culturally competent care

Arn J Schilder, Cornelis Kennedy, Irene L Goldstone, Russel D Ogden, Robert S Hogg, Michael V O’Shaughnessy

Journal:

Social Science & Medicine

Year:

2001

Language:

english

File:

PDF, 158 KB

english, 2001

3

Safety and efficacy of radioimmunotherapy with Yttrium 90 ibritumomab tiuxetan (Zevalin)

Hossein Borghaei, Russell J Schilder

Journal:

Seminars in Nuclear Medicine

Year:

2004

Language:

english

File:

PDF, 87 KB

english, 2004

4

Safety and Efficacy of Yttrium-90 Ibritumomab Tiuxetan in Older Patients With Non-Hodgkin's Lymphoma

Emmanouilides, Christos, Witzig, Thomas E., Wiseman, Gregory A., Gordon, Leo I., Wang, Hua, Schilder, Russell, Saville, M. Wayne, Flinn, Ian, Molina, Arturo

Journal:

Cancer Biotherapy & Radiopharmaceuticals

Year:

2007

Language:

english

File:

PDF, 149 KB

english, 2007

5

Phase II study of paclitaxel and estramustine in patients with recurrent and refractory non-Hodgkin lymphoma

Hossein Borghaei, Michael Millenson, Russell Schilder, Mitchell Alden, Andre Rogatko, Hao Wang, Kristin Padavic-Shaller, Mitchell R. Smith

Journal:

Year:

2004

Language:

english

File:

PDF, 98 KB

english, 2004

6

Dexamethasone plus retinoids decrease IL-6/IL-6 receptor and induce apoptosis in myeloma cells

Mitchell R. Smith, Tao Xie, Indira Joshi, Russell J. Schilder

Journal:

British Journal of Haematology

Year:

1998

Language:

english

File:

PDF, 854 KB

english, 1998

7

Phase II trial of PALA in combination with 5-fluorouracil in advanced pancreatic cancer

Elizabeth Rosyold, Russell Schilder, Judy Walczak, S. M. DiFino, P. J. Flynn, T. K. Banerjee, W. J. Heim, Paul E. Engstrom, Robert F. Ozols, Peter J. O'Dwyer

Journal:

Cancer Chemotherapy and Pharmacology

Year:

1992

Language:

english

File:

PDF, 371 KB

english, 1992

8

A Phase II trial of weekly infusional 5-fluorouracil in combination with lowdose leucovorin in patients with advanced colorectal cancer

Naomi B. Haas, Russell J. Schilder, Sherry Nash, Louis M. Weiner, Robert C. Catalano, Robert F. Ozols, Peter J. O'Dwyer

Journal:

Investigational New Drugs

Year:

1995

Language:

english

File:

PDF, 444 KB

english, 1995

9

Population pharmacokinetic and limited sampling models for carboplatin administered in high-dose combination regimens with peripheral blood stem cell support

Meiyu Shen, Russell J. Schilder, Coleman Obasaju, James M. Gallo

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2002

Language:

english

File:

PDF, 141 KB

english, 2002

10

Imatinib mesylate and its potential implications for gynecologic cancers

Holly Dushkin, Russell J. Schilder

Journal:

Current Treatment Options in Oncology

Year:

2005

Language:

english

File:

PDF, 204 KB

english, 2005

11

Evaluation of irofulven (MGI-114) in the treatment of recurrent or persistent endometrial carcinoma: A phase II study of the Gynecologic Oncology Group

Russell J. Schilder, John A. Blessing, Michael L. Pearl, Peter G. Rose

Journal:

Investigational New Drugs

Year:

2004

Language:

english

File:

PDF, 67 KB

english, 2004

12

Evaluation of Gemcitabine in Patients with Squamous Cell Carcinoma of the Cervix: A Phase II Study of the Gynecologic Oncology Group

Russell J. Schilder, John A. Blessing, Mark Morgan, Charles E. Mangan, Janet S. Rader

Journal:

Gynecologic Oncology

Year:

2000

Language:

english

File:

PDF, 42 KB

english, 2000

13

Pilot Evaluation of High-Dose Carboplatin and Paclitaxel Followed by High-Dose Melphalan Supported by Peripheral Blood Stem Cells in Previously Untreated Advanced Ovarian Cancer: A Gynecologic Oncology Group Study

Russell J. Schilder, Mark F. Brady, David Spriggs, Thomas Shea

Journal:

Gynecologic Oncology

Year:

2003

Language:

english

File:

PDF, 56 KB

english, 2003

14

Phase II evaluation of 9-aminocamptothecin (9-AC, NSC #603071) in platinum-resistant ovarian and primary peritoneal carcinoma: A Gynecologic Oncology Group Study

David Scott Miller, John A. Blessing, Steven Waggoner, Jeanne Schilder, Joel Sorosky, Jeffrey Bloss, Russell Schilder

Journal:

Gynecologic Oncology

Year:

2005

Language:

english

File:

PDF, 90 KB

english, 2005

15

Evaluation of gemcitabine in previously treated patients with non-squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group

Russell J. Schilder, John Blessing, David E. Cohn

Journal:

Gynecologic Oncology

Year:

2005

Language:

english

File:

PDF, 94 KB

english, 2005

16

Relevant molecular markers and targets

Kathleen M. Darcy, Russell J. Schilder

Journal:

Gynecologic Oncology

Year:

2006

Language:

english

File:

PDF, 164 KB

english, 2006

17

A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer

Jason Konner, Russell J. Schilder, Felicia A. DeRosa, Scott R. Gerst, William P. Tew, Paul J. Sabbatini, Martee L. Hensley, David R. Spriggs, Carol A. Aghajanian

Journal:

Gynecologic Oncology

Year:

2008

Language:

english

File:

PDF, 226 KB

english, 2008

18

Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash

Russell J. Schilder, Harsh B. Pathak, Anna E. Lokshin, Robert W. Holloway, Ronald D. Alvarez, Carol Aghajanian, Hua Min, Karthik Devarajan, Eric Ross, Charles W. Drescher, Andrew K. Godwin

Journal:

Gynecologic Oncology

Year:

2009

Language:

english

File:

PDF, 425 KB

english, 2009

19

A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: A Gynecologic Oncology Group study

Carol Aghajanian, John A. Blessing, Kathleen M. Darcy, Gary Reid, Koen DeGeest, Stephen C. Rubin, Robert S. Mannel, Jacob Rotmensch, Russell J. Schilder, William Riordan

Journal:

Gynecologic Oncology

Year:

2009

Language:

english

File:

PDF, 589 KB

english, 2009

20

Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: A Gynecologic Oncology Group study

John Farley, Michael W. Sill, Michael Birrer, Joan Walker, Russell J. Schilder, J. Tate Thigpen, Robert L. Coleman, Brigitte E. Miller, Peter G. Rose, Heather A. Lankes

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 309 KB

english, 2011

21

Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: A Gynecologic Oncology Group study

Kian Behbakht, Michael W. Sill, Kathleen M. Darcy, Stephen C. Rubin, Robert S. Mannel, Steven Waggoner, Russell J. Schilder, Kathy Q. Cai, Andrew K. Godwin, R. Katherine Alpaugh

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 763 KB

english, 2011

22

Focus on epithelial ovarian cancer

Robert F. Ozols, Michael A. Bookman, Denise C. Connolly, Mary B. Daly, Andrew K. Godwin, Russell J. Schilder, Xiangxi Xu, Thomas C. Hamilton

Journal:

Year:

2004

Language:

english

File:

PDF, 291 KB

english, 2004

23

Management of Recurrent Ovarian Carcinoma: Current Status and Future Directions

Lainie P. Martin, Russell J. Schilder

Journal:

Seminars in Oncology

Year:

2009

Language:

english

File:

PDF, 364 KB

english, 2009

24

Endodontic pathogens stimulate monocyte chemoattractant protein-1 and interleukin-8 in mononuclear cells

Yanling Jiang, Thomas R. Russell, Herbert Schilder, Dana T. Graves

Journal:

Journal of Endodontics

Year:

1998

Language:

english

File:

PDF, 462 KB

english, 1998

25

Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study

Russell J. Schilder, William E. Brady, Heather A. Lankes, James V. Fiorica, Mark S. Shahin, Xun C. Zhou, Robert S. Mannel, Harsh B. Pathak, Wei Hu, R. Katherine Alpaugh, Anil K. Sood, Andrew K. Godwin

Journal:

Gynecologic Oncology

Year:

2012

Language:

english

File:

PDF, 205 KB

english, 2012

26

Lapatinib and potential prognostic value of EGFR mutations in a Gynecologic Oncology Group phase II trial of persistent or recurrent endometrial cancer

Kimberly K. Leslie, Michael W. Sill, Heather A. Lankes, Edgar G. Fischer, Andrew K. Godwin, Heidi Gray, Russell J. Schilder, Joan L. Walker, Krishnansu Tewari, Parviz Hanjani, Ovadia Abulafia, Peter G

Journal:

Gynecologic Oncology

Year:

2012

Language:

english

File:

PDF, 723 KB

english, 2012

27

A phase I trial of tailored radiation therapy with concomitant cetuximab and cisplatin in the treatment of patients with cervical cancer: A gynecologic oncology group study

Kathleen N. Moore, Michael W. Sill, David S. Miller, Carolyn McCourt, Koen De Geest, Peter G. Rose, Higinia R. Cardenes, Robert S. Mannel, John H. Farley, Russell J. Schilder, Paula M. Fracasso

Journal:

Gynecologic Oncology

Year:

2012

Language:

english

File:

PDF, 176 KB

english, 2012

28

Phase II trial of induction high-dose chemotherapy followed by surgical resection and radiation therapy for patients with marginally resectable non-small cell carcinoma of the lung

Schilder, Russell J, Goldberg, Melvyn, Millenson, Michael M, Movsas, Benjamin, Rogatko, André, Rogers, Barbara, Langer, Corey J

Journal:

Year:

2000

Language:

english

File:

PDF, 110 KB

english, 2000

29

Factors Associated with Toxicity and Response to Yttrium 90–Labeled Ibritumomab Tiuxetan in Patients with Indolent Non-Hodgkin's Lymphoma

Borghaei, Hossein, Wallace, Stephen G., Schilder, Russell J.

Journal:

Clinical Lymphoma

Year:

2004

Language:

english

File:

PDF, 113 KB

english, 2004

30

Antilymphoma Treatments Given Subsequent to Yttrium 90 Ibritumomab Tiuxetan Are Feasible in Patients with Progressive Non-Hodgkin's Lymphoma: A Review of the Literature

Ansell, Stephen M., Schilder, Russell J., Pieslor, Peter C., Gordon, Leo I., Emmanouilides, Christos, Vo, Katie, Czuczman, Myron S., Witzig, Thomas E., Theuer, Charles, Molina, Arturo

Journal:

Clinical Lymphoma

Year:

2004

Language:

english

File:

PDF, 111 KB

english, 2004

31

Weight-Based Dosing of Yttrium 90 Ibritumomab Tiuxetan in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Wiseman, Gregory A., Conti, Peter S., Vo, Katie, Schilder, Russell J., Gordon, Leo I., Emmanouilides, Christos, Silverman, Dan H., Witzig, Thomas E., Darif, Mohamed, Molina, Arturo

Journal:

Clinical Lymphoma & Myeloma

Year:

2007

Language:

english

File:

PDF, 106 KB

english, 2007

32

Front-line treatment of epithelial ovarian cancer

Lainie Martin, Dr Russell J. Schilder

Journal:

American Journal of Cancer

Year:

2005

Language:

english

File:

PDF, 126 KB

english, 2005

33

Radiation Dosimetry Results From a Phase II Trial of Ibritumomab Tiuxetan (Zevalin™) Radioimmunotherapy for Patients With Non-Hodgkin's Lymphoma and Mild Thrombocytopenia

Wiseman, Gregory A., Leigh, Bryan R., Erwin, William D., Sparks, Richard B., Podoloff, Donald A., Schilder, Russell J., Bartlett, Nancy L., Spies, Stewart M., Grillo-López, Antonio J., Witzig, Thomas

Journal:

Cancer Biotherapy & Radiopharmaceuticals

Year:

2003

Language:

english

File:

PDF, 374 KB

english, 2003

34

Adjuvant Vaginal Cuff Brachytherapy for High-Risk, Early Stage Endometrial Cancer: A Single-Institution Experience

Eldredge-Hindy, Harriet B., Anne, Rani Pramila, Eastwick, Gary, Rosenblum, Norman, Schilder, Russell J., Chalian, Raffi, Zibelli, Allison, Kim, Christine, Den, Robert

Journal:

Year:

2014

Language:

english

File:

PDF, 273 KB

english, 2014

35

A phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study

Martin, Lainie P., Sill, Michael, Shahin, Mark S., Powell, Matthew, DiSilvestro, Paul, Landrum, Lisa M., Gaillard, Stephanie L., Goodheart, Michael J., Hoffman, James, Schilder, Russell J.

Journal:

Gynecologic Oncology

Year:

2014

Language:

english

File:

PDF, 246 KB

english, 2014

36

Influence of bevacizumab on vaginal cuff evisceration eight months after ovarian cancer cytoreduction surgery: A case report

Skwara, Amanda J., Schilder, Russell J., Zibelli, Allison, Rosenblum, Norman G.

Journal:

Gynecologic Oncology Case Reports

Year:

2013

Language:

english

File:

PDF, 699 KB

english, 2013

37

Treatment with yttrium 90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin's lymphoma

Emmanouilides, Christos, Witzig, Thomas E., Gordon, Leo I., Vo, Katie, Wiseman, Gregory A., Flinn, Ian W., Darif, Mohamed, Schilder, Russell J., Molina, Arturo

Journal:

Leukemia and Lymphoma

Year:

2006

Language:

english

File:

PDF, 352 KB

english, 2006

38

Follow-Up Results of a Phase II Study of Ibritumomab Tiuxetan Radioimmunotherapy in Patients with Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin's Lymphoma and Mild Thrombocytopenia

Schilder, Russell, Molina, Arturo, Bartlett, Nancy, Witzig, Thomas, Gordon, Leo, Murray, James, Spies, Stewart, Wang, Hua, Wiseman, Gregory, White, Christine

Journal:

Cancer Biotherapy & Radiopharmaceuticals

Year:

2004

Language:

english

File:

PDF, 70 KB

english, 2004

39

New Therapies for Ovarian Cancer

Schilder, Russell J., Ozols, Robert F.

Journal:

Cancer Investigation

Year:

1992

Language:

english

File:

PDF, 994 KB

english, 1992

40

A phase 1b study of trebananib in combination with pegylated liposomal doxorubicin or topotecan in women with recurrent platinum-resistant or partially platinum-sensitive ovarian cancer

Vergote, Ignace, Schilder, Russell J., Pippitt, Charles H., Wong, Shirley, Gordon, Alan N., Scudder, Sidney, Kridelka, Frederic, Dirix, Luc, Leach, Joseph W., Ananda, Sumitra, Nanayakkara, Nuwan, Mela

Journal:

Gynecologic Oncology

Year:

2014

Language:

english

File:

PDF, 440 KB

english, 2014

41

Rituximab Immunotherapy

Schilder, Russell

Journal:

Cancer Biotherapy & Radiopharmaceuticals

Year:

1999

Language:

english

File:

PDF, 536 KB

english, 1999

42

Adjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancer

Eldredge-Hindy, Harriet Belding, Eastwick, Gary, Anne, Pramila Rani, Rosenblum, Norman G., Schilder, Russell J., Chalian, Raffi, Zibelli, Allison M., Kim, Christine H., Den, Robert

Journal:

Journal of Contemporary Brachytherapy

Year:

2014

Language:

english

File:

PDF, 268 KB

english, 2014

43

A phase I pharmacokinetic study of intraperitoneal bortezomib and carboplatin in patients with persistent or recurrent ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study

Jandial, Danielle A., Brady, William E., Howell, Stephen B., Lankes, Heather A., Schilder, Russell J., Beumer, Jan H., Christner, Susan M., Strychor, Sandra, Powell, Matthew A., Hagemann, Andrea R., M

Journal:

Gynecologic Oncology

Year:

2017

Language:

english

File:

PDF, 604 KB

english, 2017

44

A phase I trial of intraperitoneal GEN-1, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer, administered with pegylated liposomal doxorubicin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancers: An NRG Oncology/Gynecologic Oncology Group study

Thaker, Premal H., Brady, William E., Lankes, Heather A., Odunsi, Kunle, Bradley, William H., Moore, Kathleen N., Muller, Carolyn Y., Anwer, Khursheed, Schilder, Russell J., Alvarez, Ronald D., Fracas

Journal:

Gynecologic Oncology

Year:

2017

Language:

english

File:

PDF, 712 KB

english, 2017

45

Sorafenib in Combination With Gemcitabine in Recurrent Epithelial Ovarian Cancer

Welch, Stephen A., Hirte, Hal W., Elit, Laurie, Schilder, Russel J., Wang, Lisa, MacAlpine, Katrina, Wright, John J., Oza, Amit M.

Journal:

International Journal of Gynecological Cancer

Year:

2010

Language:

english

File:

PDF, 866 KB

english, 2010

46

Aurora A Functional Single Nucleotide Polymorphism (SNP) Correlates With Clinical Outcome in Patients With Advanced Solid Tumors Treated With Alisertib, an Investigational Aurora A Kinase Inhibitor

Niu, Huifeng, Shin, Hyunjin, Gao, Feng, Zhang, Jacob, Bahamon, Brittany, Danaee, Hadi, Melichar, Bohuslav, Schilder, Russell J., Coleman, Robert L., Falchook, Gerald, Adenis, Antoine, Behbakht, Kian,

Journal:

Year:

2017

Language:

english

File:

PDF, 1.42 MB

english, 2017

47

Novel Non-Cytotoxic Therapy in Ovarian Cancer: Current Status and Future Prospects

Martin, Lainie, Schilder, Russell J.

Journal:

Journal of the National Comprehensive Cancer Network

Year:

2006

Language:

english

File:

PDF, 861 KB

english, 2006

48

A Synthetic Lethality Screen Using a Focused siRNA Library to Identify Sensitizers to Dasatinib Therapy for the Treatment of Epithelial Ovarian Cancer

Pathak, Harsh B., Zhou, Yan, Sethi, Geetika, Hirst, Jeff, Schilder, Russell J., Golemis, Erica A., Godwin, Andrew K., Orsulic, Sandra

Journal:

Year:

2015

Language:

english

File:

PDF, 1.89 MB

english, 2015

49

Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes

Toss, Angela, Tomasello, Chiara, Razzaboni, Elisabetta, Contu, Giannina, Grandi, Giovanni, Cagnacci, Angelo, Schilder, Russell J., Cortesi, Laura

Journal:

BioMed Research International

Year:

2015

Language:

english

File:

PDF, 2.43 MB

english, 2015

50

Refractory fallopian tube carcinoma – current perspectives in pathogenesis and management

Schilder, Russell, Sama, Ashwin

Journal:

International Journal of Women's Health

Year:

2014

Language:

english

File:

PDF, 633 KB

english, 2014

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски